Robert C Kern Selected Research

Robert C Kern Research Topics

Disease

65	Rhinosinusitis 11/2022 - 09/2005
55	Nasal Polyps (Nasal Polyp) 11/2022 - 10/2003
17	Asthma (Bronchial Asthma) 01/2022 - 10/2003
15	Polyps 11/2022 - 09/2004
15	Inflammation (Inflammations) 01/2022 - 09/2004
6	Hypersensitivity (Allergy) 01/2022 - 03/2005
6	Sinusitis 01/2018 - 10/2003
5	Infections 01/2021 - 05/2012
5	Eosinophilia 11/2017 - 09/2004
3	Rhinitis 01/2020 - 03/2011
3	Edema (Dropsy) 01/2019 - 01/2013
2	Anosmia 11/2019 - 03/2008
2	Gastroesophageal Reflux (GERD) 05/2013 - 11/2009
2	Brain Injuries (Brain Injury) 01/2013 - 12/2005
2	Neoplasms (Cancer) 09/2008 - 12/2005
2	Septic Shock (Toxic Shock Syndrome) 09/2005 - 09/2004
2	Atopic Dermatitis (Atopic Eczema) 10/2004 - 09/2004
1	Thrombosis (Thrombus) 01/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022
1	COVID-19 10/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Bronchiectasis 12/2019
1	Cicatrix (Scar) 01/2019
1	Bacterial Infections (Bacterial Infection) 12/2017
1	Pneumonia (Pneumonitis) 07/2017
1	Cerebrospinal Fluid Leak 03/2017

Drug/Important Bio-Agent (IBA)

12	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 05/2009
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 10/2003
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2013
8	Messenger RNA (mRNA)IBA 01/2017 - 03/2010
7	AntibodiesIBA 01/2022 - 10/2004
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
7	SuperantigensIBA 11/2009 - 09/2004
6	FibrinIBA 11/2022 - 01/2013
6	CytokinesIBA 01/2017 - 09/2004
5	SteroidsIBA 01/2019 - 10/2003
5	EnzymesIBA 11/2017 - 09/2004
5	AllergensIBA 06/2017 - 03/2005
4	Immunoglobulin G (IgG)IBA 01/2022 - 12/2011
4	Immunoglobulin E (IgE)IBA 01/2021 - 09/2004
4	Thymic Stromal LymphopoietinIBA 01/2020 - 09/2013
4	ImmunosorbentsIBA 11/2017 - 09/2004
3	Interleukin-13IBA 11/2022 - 12/2015
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 11/2022 - 01/2018
3	mepolizumabIBA 07/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 12/2011
3	dupilumabIBA 01/2022 - 01/2020
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2013
3	Cyclooxygenase 1IBA 01/2021 - 07/2017
3	LigandsIBA 01/2017 - 01/2012
3	ExotoxinsIBA 09/2005 - 09/2004
2	Interleukin-5 (Interleukin 5)IBA 11/2022 - 01/2022
2	Eosinophil Cationic ProteinIBA 01/2022 - 11/2017
2	benralizumabIBA 09/2021 - 01/2020
2	Omalizumab (Xolair)FDA Link 09/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 07/2017
2	Biological ProductsIBA 01/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 02/2010
2	S100 Proteins (S 100 Protein)IBA 11/2015 - 03/2010
2	Blood Proteins (Serum Proteins)IBA 09/2013 - 01/2013
2	ChemokinesIBA 07/2011 - 02/2010
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2006 - 07/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022
1	fibrin fragment D (D-dimer)IBA 11/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2022
1	RetinoidsIBA 11/2022
1	Iron-Dextran Complex (InFed)FDA Link 01/2022
1	AZD1981IBA 01/2022
1	CoagulantsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Nucleic AcidsIBA 10/2021
1	reslizumabIBA 09/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	IntegrinsIBA 12/2020
1	RANK LigandIBA 01/2020
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2019
1	OF 900IBA 12/2019
1	MucinsIBA 11/2019
1	ProcalcitoninIBA 03/2019
1	Interleukin-33IBA 11/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Immunoglobulin D (IgD)IBA 12/2017
1	lysolecithin acylhydrolaseIBA 10/2017
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 07/2017
1	Staphylococcal Protein A (Protein A)IBA 07/2017
1	Oncostatin MIBA 06/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 06/2017
1	Proton Pump InhibitorsIBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2021 - 07/2003
2	Biological Therapy 01/2022 - 01/2016
1	Stents 11/2022
1	Catheters 07/2020